BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16538453)

  • 1. Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.
    Gao W; Wang YS; Zhang P; Wang HY
    Graefes Arch Clin Exp Ophthalmol; 2006 Oct; 244(10):1246-9. PubMed ID: 16538453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia and central retinal vein occlusion in Iranian population.
    Moghimi S; Najmi Z; Faghihi H; Karkhaneh R; Farahvash MS; Maghsoudipour M
    Int Ophthalmol; 2008 Feb; 28(1):23-8. PubMed ID: 17636432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma homocysteine concentrations in the acute phase after central retinal vein occlusion in a Chinese population.
    Dong N; Wang B; Chu L; Xiao L
    Curr Eye Res; 2013 Nov; 38(11):1153-8. PubMed ID: 23885778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population.
    Narayanasamy A; Subramaniam B; Karunakaran C; Ranganathan P; Sivaramakrishnan R; Sharma T; Badrinath VS; Roy J
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1441-6. PubMed ID: 17389469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma homocysteine concentrations in acute and convalescent changes of central retinal vein occlusion in a Chinese population.
    Dong N; Xu B; Tang X
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4057-62. PubMed ID: 24906854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and retinal vascular occlusive disease.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro SA; Al-Attas OS
    Eur J Ophthalmol; 2002; 12(6):495-500. PubMed ID: 12510718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia: a risk factor for retinal vein occlusion.
    Yildirim C; Yaylali V; Tatlipinar S; Kaptanoğlu B; Akpinar S
    Ophthalmologica; 2004; 218(2):102-6. PubMed ID: 15004498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MTHFR C677T mutation in central retinal vein occlusion: a case-control study in Chinese population.
    Gao W; Wang YS; Zhang P; Wang HY
    Thromb Res; 2008; 121(5):699-703. PubMed ID: 17719079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia: a risk factor for central retinal vein occlusion.
    Vine AK
    Am J Ophthalmol; 2000 May; 129(5):640-4. PubMed ID: 10844057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.
    Lahiri KD; Mukherjee S; Ghosh S; Mukherjee S; Dutta J; Datta H; Das HN
    Korean J Ophthalmol; 2015 Apr; 29(2):86-91. PubMed ID: 25829824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion.
    Lattanzio R; Sampietro F; Ramoni A; Fattorini A; Brancato R; D'Angelo A
    Retina; 2006 Jan; 26(1):65-70. PubMed ID: 16395141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hyperhomocysteinemia and Vitamin B12 deficiency in central and hemi-central retinal vein occlusion: A case-control study.
    Arthur D; John D; Fleming JJ; Rebekah G; Gowri M; John SS
    Oman J Ophthalmol; 2022; 15(1):6-12. PubMed ID: 35388251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma homocysteine in patients with retinal vein occlusion.
    Minniti G; Calevo MG; Giannattasio A; Camicione P; Armani U; Lorini R; Piana G
    Eur J Ophthalmol; 2014; 24(5):735-43. PubMed ID: 24519513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.
    Vine AK
    Trans Am Ophthalmol Soc; 2000; 98():493-503. PubMed ID: 11190038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia in central retinal vein occlusion in young adults.
    Parodi MB; Di Crecchio L
    Semin Ophthalmol; 2003 Sep; 18(3):154-9. PubMed ID: 15513477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vitamins B6, B12 and folic acid on hyperhomocysteinemia in a Pakistani population of patients with acute myocardial infarction.
    Iqbal MP; Ishaq M; Kazmi KA; Yousuf FA; Mehboobali N; Ali SA; Khan AH; Waqar MA
    Nutr Metab Cardiovasc Dis; 2005 Apr; 15(2):100-8. PubMed ID: 15871858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion.
    Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Quehenberger F; Semmelrock J; Haas A
    Ophthalmology; 2002 Jun; 109(6):1105-9. PubMed ID: 12045051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion.
    Sodi A; Giambene B; Marcucci R; Sofi F; Fedi S; Abbate R; Prisco D; Menchini U
    Retina; 2011 Apr; 31(4):724-9. PubMed ID: 21178660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.